Biofrontera (BFRI) Gains from Sales and Divestitures (2022 - 2025)
Historic Gains from Sales and Divestitures for Biofrontera (BFRI) over the last 4 years, with Q3 2025 value amounting to $225000.0.
- Biofrontera's Gains from Sales and Divestitures rose 461599.25% to $225000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $225000.0, marking a year-over-year increase of 461599.25%. This contributed to the annual value of $4771.0 for FY2024, which is 4444.57% down from last year.
- Biofrontera's Gains from Sales and Divestitures amounted to $225000.0 in Q3 2025, which was up 461599.25% from $4771.0 recorded in Q4 2024.
- In the past 5 years, Biofrontera's Gains from Sales and Divestitures registered a high of $170.1 million during Q2 2022, and its lowest value of $4771.0 during Q2 2024.
- For the 4-year period, Biofrontera's Gains from Sales and Divestitures averaged around $18.9 million, with its median value being $8588.0 (2023).
- Per our database at Business Quant, Biofrontera's Gains from Sales and Divestitures plummeted by 9495.03% in 2023 and then skyrocketed by 461599.25% in 2025.
- Quarter analysis of 4 years shows Biofrontera's Gains from Sales and Divestitures stood at $8504.0 in 2022, then increased by 0.99% to $8588.0 in 2023, then plummeted by 44.45% to $4771.0 in 2024, then soared by 4615.99% to $225000.0 in 2025.
- Its Gains from Sales and Divestitures stands at $225000.0 for Q3 2025, versus $4771.0 for Q4 2024 and $4771.0 for Q3 2024.